Category: Biotech Stocks

  Street Calls of the Week: What Wall Street’s Latest Analyst Ratings Mean for Investors Wall Street analyst upgrades and downgrades can off...

  Nvidia-Backed Iambic Therapeutics Launches IPO: Can AI Transform Drug Discovery? Iambic Therapeutics is moving toward a US stock-market de...

  Why Is Atrium Therapeutics Stock Surging Today? $50 Million Financing Boosts RNA Shares Atrium Therapeutics (NASDAQ: RNA) is in focus on O...

  Spyre Therapeutics Stock Falls After $350 Million Public Offering Spyre Therapeutics stock fell in after-hours trading after the clinical-...

  Pyxis Oncology Stock Falls After Public Offering Announcement Shares of Pyxis Oncology (NASDAQ: PYXS) fell in after-hours trading on Sept...

  Dyne Therapeutics Stock Rises After Positive DM1 Trial Results Shares of Dyne Therapeutics (NASDAQ: DYN) moved higher in after-hours trad...

  B. Riley Names 4D Molecular Therapeutics a Top Biotech Pick B. Riley Securities has reaffirmed 4D Molecular Therapeutics (NASDAQ: FDMT) a...

  Why Is Vanda Pharmaceuticals Stock Surging Today? VNDA Rally Explained Vanda Pharmaceuticals (NASDAQ: VNDA) is attracting strong buying i...

  Liquidia: High Growth, Demanding Valuation in the Mid-Cap Biotech Space Liquidia Corporation (NASDAQ: LQDA) has moved well beyond the prof...